# George D. Demetri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/george-d-demetri-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 64,264 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 115 |
| i10-index | 297 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5060580923 |
| ORCID iD | https://orcid.org/0000-0002-0045-4809 |
| Works | 637 |

## Researcher papers

- [NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/nccn-task-force-report-update-on-the-management-of-patients-with/)
- [Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-or-dacarbazine-for-metastatic-liposarcoma-or/)
- [Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-in-patients-with-advanced-or-metastatic/)
- [A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response](https://scholariq.org/papers/a-murine-lung-cancer-co-clinical-trial-identifies-genetic-modifiers-of/)
- [Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/hypothyroidism-after-sunitinib-treatment-for-patients-with-gastrointestinal/)
- [The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers](https://scholariq.org/papers/the-neuroblastoma-associated-f1174l-alk-mutation-causes-resistance-to-an-alk/)
- [Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial](https://scholariq.org/papers/afamitresgene-autoleucel-for-advanced-synovial-sarcoma-and-myxoid-round-cell/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.